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Abstract 
Meningeal melanocytoma is a benign lesion
arising from leptomeningeal melanocytes that
at times can mimic its malignant counterpart,
melanoma.  Lesions of the spine usually occur
in extramedullary locations and present with
spinal cord compression symptoms. Because
most reported spinal cases occur in the tho-
racic region, these symptoms usually include
lower extremity weakness or numbness. The
authors  present  a  case  of  primary  intrame  -
dullary spinal meningeal melanocytoma pre-
senting with bilateral lower extremity symp-
toms  in  which  the  patient  had  no  known
supratentorial  primary  lesions.    Gross  total
surgical resection allowed for full recovery, but
early  recurrence  of  tumor  was  detected  on
close follow-up monitoring, allowing for elec-
tive local radiation without loss of neurologi-
cal function. Case reports of such tumors dis-
cuss different treatment strategies, but just as
important is the close follow-up monitoring in
these patients even after gross total surgical
resection, since these tumors can recur.  
Introduction  
Melanocytomas (meningeal melanocytoma)
are benign, though at times locally aggressive,
tumors that arise from melanocytes within the
leptomeninges along the neuraxis.  Although
melanocytomas are most commonly found in
the posterior fossa, spinal lesions have also
been  reported.
1-11 The  majority  of  these  lep-
tomeningeal tumors are extramedullary, and
only a handful of intramedullary tumors have
been reported. As with most rare tumors, only
case reports are available for reference; thus,
no gold standard exists for the definitive treat-
ment  and  follow-up  of  patients  with  these
tumors.  Most authors favor complete resec-
tion whenever possible, with some reports of
radiation  for  incompletely  resected
lesions.
1,5,7,9,12-14 As  more  reports,  with  longer
follow-up periods of patients with these rare
tumors are presented, we may better under-
stand the natural history, aggressive nature,
and response of meningeal melanocytomas to
various treatments. In this report, the authors
describe  a  very  rare  patient  with  intra -
medullary  spinal  melanocytoma  with  no
supratentorial  primary  lesion.    After  gross
total resection, a three-month follow-up mag-
netic resonance (MR) imaging study demon-
strated a small nodule concerning for tumor
recurrence;  therefore,  close  follow-up  moni-
toring was undertaken.  
This  emphasizes  the  importance  of  close
monitoring in these patients, even in situa-
tions of gross total resection.
Case Report
History and presentation
A 45-year-old previously healthy man noticed
over  a  period  of  nine  months  an  increasing
pain,  weakness  and  numbness  in  both  legs,
with  the  right  leg  being  more  affected.  His
symptoms became apparent to him when his
daily  sporting  activities  began  suffering.
Stumbling and feelings of his legs “giving out”
prompted him to visit his primary care physi-
cian. Lumbar spine MR imaging revealed a focal
disc bulge, and the patient was referred to a
physical therapy program for conservative man-
agement. After approximately seven months of
therapy  without  resolution  of  symptoms,  the
patient  developed  bowel  and  bladder  urgency
without frank incontinence, which prompted a
return visit to his primary care physician.  
Preoperative imaging and evaluation
Further evaluation by MR imaging of the
thoracic  spine  revealed  a  space-occupying,
contrast-enhancing mass within the thoracic
spinal  cord  at  the  level  of  T11,  measuring
17¥12¥10 mm. The mass was hyperintense
on T1-weighted imaging and hypointense on
T2-weighted sequences, and full radiographic
evaluation  supported  a  diagnosis  of
intramedullary lesion (Figure 1).  The areas
superior  and  inferior  to  the  lesion  showed
evidence of local edema and early syrinx for-
mation.
The results of the neurological examination
revealed  the  patient  had  full  strength  with
decreased sensation and 3+ reflexes in both
legs.  He did not exhibit any clonus, Hoffmann
or  Babinski  reflexes.  The  remainder  of  his
neurological  and  general  physical  examina-
tion was unremarkable.  
Operative treatment
The  differential  diagnosis  for  the  lesion
included  ependymoma,  astrocytoma  and  the
rarer  glioma  and  metastasis.  The  patient
underwent decompression and removal of the
mass to obtain a tissue biopsy. Preoperative
motor  and  sensory  evoked  potentials  were
measured to be used as baseline comparisons.
An  incision  was  planned  to  span  T10-T12.
Intraoperative  fluoroscopy  was  used  to  con-
firm  each  level.  A  complete  laminectomy  of
T10 and T11 was completed. Ultrasonography
confirmed the tumor to be under the laminec-
tomy site. Using microsurgical technique, the
dura and arachnoid were opened, exposing a
reddish mass medially near the myelotomy. A
micro-cottonoid  was  used  to  find  a  plane
above and below the lesion. A combination of
careful dissection and a Cavitron ultrasonic
surgical aspirator was used to remove nearly
the entire tumor. Most of the highly pigment-
ed soft tumor was resected (Figure 2), and
intraoperative  specimens  were  sent  for
histopathological analysis. Unfortunately, the
intraoperative frozen samples were inconclu-
sive,  and  the  fresh  diagnosis  included
metastatic  melanoma  or  meningioma.
Because of safety concerns, aggressive resec-
tion  of  abnormally  stained  (possibly  hemo-
siderin) tissue visualized deep within the cav-
ity  was  not  attempted,  after  the  soft  tumor
bulk was removed.  
Histopathology
Permanent  tissue  was  analyzed  as  three
separate  aspirates  from  the  soft  pigmented
tumor  bulk.  Pathology  specimens  were
immunohistochemically  stained  with  MIB-1
for proliferating cells and an antibody directed
against collagen IV. The MIB-1 stain failed to
reveal  significant  numbers  of  proliferating
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neoplastic cells. Pericellular collagen IV, which
is usually associated with the neoplastic cells,
was also noticeably absent in this specimen;
this  may  be  indicative  of  artifactual  loss  of
detectable epitope.
Postoperative care and follow-up
Postoperatively,  the  patient  experienced
loss of motor ability in his left hamstring and
quadriceps  femoris  muscle  with  decreased
motor strength in other left leg muscle groups
with  normal  sensation.  The  patient  quickly
regained motor function in his left leg and did
not have any problems with his right leg post-
operatively.  He began walking with physical
therapy  on  a  daily  basis  with  increased
strength  and  ambulatory  ability  throughout
his  hospital  stay.  He  was  discharged  to  the
inpatient rehabilitation unit on postoperative
day four in stable condition. He continued to
improve and was discharged four days after
starting rehabilitation. 
Immediate postoperative MR imaging scans
demonstrated a gross total resection (Figure
1),  and  after  discussion  with  a  multifocal
tumor board, it was decided to monitor this
patient  carefully  with  serial  MR  imaging  to
watch for recurrence. At the three-month fol-
low-up  appointment,  MR  imaging  showed  a
very  small  nodule  that  was  concerning  for
recurrent tumor. Since the patient remained
asymptomatic,  this  was  monitored  with  fre-
quent MR imaging studies.  Continued growth
of  this  nodule  was  observed  on  subsequent
clinic  visits  and  imaging  studies,  although
approximately  one  year  after  surgery,  the
patient  remained  neurologically  intact  with
full  strength  and  sensation.  He  did  report
some mild neuropathic pain in his legs, which
was  controlled  with  pregabalin.  At  the  two-
year  post-operative  follow-up  examination,
MR imaging showed evidence that the nodule,
although about half the size of the original
tumor,  had  doubled  in  size  since  originally
noticed post-operatively. Since the patient was
noticing more pain in his legs and back, dis-
cussion of treatment options ensued. A multi-
disciplinary  treatment  Tumor  Board
Committee decided to initiate radiation thera-
py with close monitoring instead of surgical
re-resection.  The  patient  underwent  25-30
treatments of intensity-modulated fractionat-
ed radiation therapy, and completed a total of
5040cGy to the recurrent nodule.  The patient
is now three years post-surgical resection and
neurologically stable with minimal back pain,
leg  weakness  and  numbness.  He  undergoes
surveillance MR imaging at six-month inter-
vals and has no signs of tumor recurrence.
Case Report
Figure  1.  MR  imaging  showing  preoperative  (A,  B,  C)  and  postoperative  (D,  E)  imaging  characteristics  of  the T11  intradural
intramedullary spinal mass. (A) Preoperative T1-weighted image without gadolinium enhancement showing the approximately 1.7 cm
lesion. (B) Preoperative T1-weighted image with gadolinium enhancement showing homogeneous enhancement of the lesion, which is
not significantly enhancing over the non-contrasted T1 scan.  (C) Preoperative T2-weighted image showing syrinx formation both ros-
tral and caudal to the lesion.  (D, E) Postoperative T1- and T2-weighted images, respectively, showing near-complete resection of the
mass with postoperative intramedullary cavity.
Figure 2.  Intraoperative photographs showing the pigmented lesion coming near the
surface of the spinal cord (A); myelotomy was required to expose the tumor surface (B).
Tissue biopsy was taken with micropituitary forceps (C), and the remaining mass was
aspirated (D).  
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Discussion 
Intramedullary melanocytomas of the spine
are  an  exceedingly  rare  subclass  within  the
spectrum of primary melanocytic neoplasms of
the central nervous system (CNS), for which
very little data exist to guide clinicians in man-
agement  of  patients  post-surgical  resection.
Our current case illustrates the locally aggres-
sive nature of this benign tumor and reiterates
the importance of a multimodal approach to
less well-described tumor entities of the CNS.
Large case series or clinical studies may never
be possible because of the rarity of this tumor
entity;  however,  reportable  long-term  case
reports  carefully  correlating  intraoperative
observation, histopathologic findings and radi-
ographic  information  with  tumor  recurrence
and post-operative management will continue
to improve our understanding of these tumors
and allow us providing the most appropriate
care for patients with this condition.  
These  tumors  were  first  described  as
meningeal melanocytoma by Limas and Tio in
1972
15;  electron  microscopy  of  the  biopsied
mass  in  their  case  showed  numerous
melanosomes  within  spindle-shaped  cells.
Clinical  histopathological  studies  have  since
shown that the spectrum of CNS melanocytic
tumors  ranges  from  well-differentiated
melanocytes on one end to extremely malig-
nant  melanoma  on  the  other.
Histopathological  analysis  also  reveals
immunoreactivity for HBM-45 and S-100 pro-
tein but not for epithelial membrane antigen.
These tumors usually have low mitotic indices
and regular, small eosinophilic nuclei,
16 as in
our patient, who had a notable lack of MIB-1
staining in the tumor specimen. The cell of ori-
gin  is  the  leptomeningeal  melanocyte,  and
tumors  are  almost  exclusively  found  in  the
posterior fossa with spinal cord lesions being
most  commonly  extramedullary.  However,
these tumors can occur anywhere along the
neural axis.  Intraoperatively, surgeons usually
encounter  a  grossly  localized,  soft  but  solid,
encapsulated  pigmented  mass,  usually  with
meningeal  attachment.
5,11,16 Diagnosis  at  the
time of surgery is often difficult and mislead-
ing, as distinct cell types are not obvious until
frozen  pathological  analysis  is  completed.
Crush  preparations  obtained  in  one  case
showed  multiple  homogeneous-looking  cells
with intracellular inclusions of pigment.
17 The
diagnosis  of  meningeal  melanocytoma  was
then  confirmed  using  conventional  frozen
pathological evaluation.
About 50 to 60 diagnosed cases have been
reported in the literature since 1912, approxi-
mately  one  third  in  spine  and  two  thirds
intracranially.
5,7 A total of only a dozen patients
with  intramedullary  spinal  cord  meningeal
melanocytomas  have  been  reported,  only  a
fraction  of  whom  underwent  resection  via
myelotomy.
1,5 Spinal lesions are more common
in women, typically in their fifth decade, with
multiyear history of myelopathy with or with-
out radiculopathy. Surgical goals are to decom-
press the spinal cord and obtain a complete
resection with a specimen for diagnosis.  Local
control rates have been shown to be four times
higher if complete resection is achieved, and
morbidity and mortality rates for incomplete
resection  now  mandate  the  use  of  adjuvant
radiation therapy.
1,5,12-14 Although they are con-
sidered to be a benign tumor, melanocytomas
have been reported to recur, even after gross
total resection, as in the present case.
5 Enough
clinical  evidence  exists,  based  on  multiple
small  case  reports  and  series,  to  show  that
gross total resection is the initial treatment of
choice  for  the  management  of  these
tumors;
1,5,12-14 however,  the  question  remains
about the best possible follow-up method for
post-surgical patients and how residual tumor
or recurrences should be managed. Rades and
Schild
13 have proposed high-dose local radia-
tion, even in cases of complete tumor resec-
tion, to prevent local recurrence. More aggres-
sive  approaches  have  also  been  advocated,
including re-resection of recurring tumor and
reservation of adjuvant radiotherapy for those
lesions that cannot be completely resected.
2,3
Very  few  long-term  follow-up  studies  have
been  presented,  especially  in  those  patients
with recurrence after radiographic gross total
resection, to show which treatment provides
the best survival benefit.  
We emphasize the importance of very close
post-operative monitoring and diligent follow-
up, even in the case of radiographically gross
total resection. Although they are histopatho-
logically benign tumors, spinal intramedullary
melanocytomas do have an aggressive clinical
course  secondary  to  their  location  and  the
mass effect they impose within the spinal cord.
It is therefore crucial that recurrence post-sur-
gical resection be caught early, as this allows
for early adjuvant therapy or re-resection. As in
our patient, in whom gross total resection was
achieved, local recurrence is possible as early
as 3 months post-operatively. Clinicians should
be  aware  of  the  recurrence  risks  of  these
tumors,  because  of  their  aggressive  nature,
even after a surgical resection. Although no
large series exists to conclusively determine
why such benign tumors may recur locally, we
propose  a  possible  explanation.  As  noted  in
intraoperative reports from our case as well as
others,
3 pigmented tissues may remain in the
tumor bed after removal of the soft, pigmented
tumor mass. These tissues may be thought to
be  structurally  normal  with  possible  hemo-
siderin staining, and therefore not in need of
aggressive resection; however, it is unknown
whether  these  pigmented  so-called  normal
regions actually have tumor cells coating them
or even incorporated within them. The aggres-
sive nature of melanocytomas has been docu-
mented  by  Chacko  and  Rajshekhar,
3 who
observed what they referred to as an infiltra-
tive residue of the spinal cord substance dur-
ing intraoperative inspection of the resection
cavity of the tumor at the poles. This exact type
of tissue is the unknown aspect of the surgical
resection,  and  even  though  these  authors
advocated a radical excision procedure, they
did not report aggressive resection of the infil-
trative portions from the spinal cord. Although
their  patient  showed  no  radiographic  recur-
rence at eight years post-surgery, the infiltra-
tive nature as well as aggressive and seeming-
ly inconsistent behavior of this tumor must be
taken into account intraoperatively as well as
radiographically at follow-up.  
The risks of recurrence or residual tumor
progression  are  quite  serious,  and  several
reports describe malignant transformation as
well  as  leptomeningeal  seeding  even  years
after surgical resection.
2,18,19 Spread beyond the
scope  of  surgical  resection  dramatically
reduces  treatment  options  and  places  the
patient  at  significant  risk  of  neurological
deficits,  while  malignant  transformation
reduces effectiveness of treatments.  To mini-
mize these risks, we employed a multidiscipli-
nary tumor board at our institution, to help
with  decision-making.  We  believe  that  pre-
senting  these  rare  tumors  at  such  a  venue
allows for a broader sense of understanding
and will hopefully inform the larger oncological
community as to the nature of these benign
but aggressive lesions. Although our patient
was treated with intensity-modulated radiation
therapy for local recurrence, operative resec-
tion of locally recurrent tumor is also a reason-
able  method  of  treatment.  Considering  the
location of the tumor in our patient, close fol-
low-up with regular surveillance MR imaging
has been crucial, since re-resection has sub-
stantial associated morbidity.  Hopefully, more
reports and longer follow-up periods after sur-
gical  resection,  recurrence  and  subsequent
treatment will enable clinicians to render more
accurate information as to the best treatment
for melanocytomas as well as the best method
for dealing with their recurrence.  This may
include altering treatment decisions based on
intraoperative  findings,  such  as  normal-
appearing neural tissue stained with pigmen-
tation, even after gross total resection.  The
question  remains  whether  more  aggressive
early  adjuvant  therapy  should  play  a  role  in
treating patients with these benign, yet locally
aggressive intramedullary tumors.
Case Report
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